Schoenemeyer Annett, Barnes Betsy J, Mancl Margo E, Latz Eicke, Goutagny Nadege, Pitha Paula M, Fitzgerald Katherine A, Golenbock Douglas T
Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
J Biol Chem. 2005 Apr 29;280(17):17005-12. doi: 10.1074/jbc.M412584200. Epub 2005 Jan 28.
Interferon regulatory factors (IRFs) are critical components of virus-induced immune activation and type I interferon regulation. IRF3 and IRF7 are activated in response to a variety of viruses or after engagement of Toll-like receptor (TLR) 3 and TLR4 by double-stranded RNA and lipopolysaccharide, respectively. The activation of IRF5, is much more restricted. Here we show that in contrast to IRF3 and IRF7, IRF5 is not a target of the TLR3 signaling pathway but is activated by TLR7 or TLR8 signaling. We also demonstrate that MyD88, interleukin 1 receptor-associated kinase 1, and tumor necrosis factor receptor-associated factor 6 are required for the activation of IRF5 and IRF7 in the TLR7 signaling pathway. Moreover, ectopic expression of IRF5 enabled type I interferon production in response to TLR7 signaling, whereas knockdown of IRF5 by small interfering RNA reduced type I interferon induction in response to the TLR7 ligand, R-848. IRF5 and IRF7, therefore, emerge from these studies as critical mediators of TLR7 signaling.
干扰素调节因子(IRFs)是病毒诱导的免疫激活和I型干扰素调节的关键组成部分。IRF3和IRF7分别在受到多种病毒刺激后,或在双链RNA和脂多糖分别与Toll样受体(TLR)3和TLR4结合后被激活。IRF5的激活则受到更多限制。在此我们表明,与IRF3和IRF7不同,IRF5不是TLR3信号通路的靶点,而是由TLR7或TLR8信号激活。我们还证明,髓样分化因子88(MyD88)、白细胞介素1受体相关激酶1和肿瘤坏死因子受体相关因子6是TLR7信号通路中激活IRF5和IRF7所必需的。此外,IRF5的异位表达能够使细胞在受到TLR7信号刺激时产生I型干扰素,而通过小干扰RNA敲低IRF5则会减少细胞对TLR7配体R-848的刺激产生I型干扰素。因此,从这些研究中可以看出,IRF5和IRF7是TLR7信号的关键介质。